-
Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease
drugs
August 01, 2019
A U.S. clinical trial of CRISPR gene-editing to treat people with sickle cell disease is underway.
-
Lonza, Vineti Enter Cell and Gene Therapy Network Alliance
contractpharma
July 31, 2019
Integrated offering includes logistics, scheduling, distribution, Chain of Condition, Chain of Custody, Chain of Identity, and Lonza’s MODA-ES.
-
One Gene Change 2 Million Years Ago Left Humans Vulnerable to Heart Attack
drugs
July 30, 2019
As far as scientists know, humans are the only species that get heart attacks linked to clogged arteries.
-
AveXis, BIA Ink Gene Therapy Manufacturing Process Development Deal
contractpharma
July 29, 2019
BIA to provide expertise in next generation biomolecule purification processes and long-term supply of CIMmultus monolithic columns.
-
First U.S. Trial Using CRISPR Within the Body Set to Begin
drugs
July 26, 2019
In a U.S. first, a clinical trial to begin this fall will use the inside-the-body gene-editing technique CRISPR to try to cure illness.
-
Passage Bio Announces New Gene Therapy Manufacturing Suite
contractpharma
July 11, 2019
Dedicated cGMP suite to be built under partnership agreement with Paragon Gene Therapy .
-
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
prnasia
July 08, 2019
The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative.
-
Amicus, Catalent Biologics Enter Gene Therapy Mfg. Pact
contractpharma
July 03, 2019
Will support clinical and commercial supply needs for Pompe and other Lysosomal Disease Gene Therapy Programs.
-
PTC Therapeutics, Odylia Therapeutics Enter Gene Therapy Alliance
contractpharma
July 03, 2019
Expands PTC's gene therapy portfolio to rare ophthalmic diseases .
-
Alzheimer's Genes Might Show Effects in Your 20s
drugs
June 28, 2019
Alzheimer's Genes Might Show Effects in Your 20s.